IL13 and Alzheimer disease: Choi et al. [26] have reported that oral administration of miquelianin, which activates Nrf2 ex vivo, suppresses ear thickening and inflammatory cell infiltration, reduces serum IgE production in trimellitic anhydride-induced AD model mice, and alleviates IL-13 production in lymph nodes.